Who Really Signs the Check? Selling Healthtech in the U.S. Market

Send us Fan Mail

Most founders don’t lose U.S. deals because of their product…
they lose because they pitch to the wrong person.

And that’s exactly what we’re breaking down live this week.

If you're building or selling in healthtech and you still assume the clinician is the buyer… you’re already behind.
Because the people who love your product?
They’re rarely the people who sign the contract.

This session is the wake-up call most European teams don’t get until they’ve burned years of budget, time, and trust.

We’re going deep into:
• Who actually controls healthcare budgets in the U.S.
• Why FDA clearance opens doors but ROI closes deals
• How payers, employers, and providers think and what moves them
• The one question that decides whether you’re ready to sell here

If you’re not in the room, you’ll spend the next 12–18 months learning this the hard way.

Ask questions. Fix your GTM before it costs you.

→ Don’t miss it. This conversation can save you years.

LinkedIn | WEBSITE